Chen Siqi

vankochensq@163.com

A SEMINAR aimed at strengthening collaborative efforts in the biomedicine industry between Shenzhen and Hong Kong was held Friday at the Shenzhen-Hong Kong International Science and Technology Park, which is located in the Hetao Shenzhen-Hong Kong Science and Technology Innovation Cooperation Zone.

Approximately 120 experts, entrepreneurs, researchers, and industry insiders attended the seminar.

Dr. Arieh Warshel, an American-Israeli chemist who was awarded the Nobel Prize in Chemistry in 2013 and serves as a distinguished professor at The Chinese University of Hong Kong, Shenzhen (CUHK-SZ), delivered a speech on the use of computer simulations and physical analysis to fight diseases.

With extensive experience in drug development and biological mechanism studies with computational modeling, Dr. Warshel founded the Warshel Institute for Computational Biology in CUHK-SZ in 2017. One of the world’s most advanced computational biology centers, the institute nurtures talent in bioinformatics and systems biology.

“I enjoy what I do. It is rewarding to witness the development and growth in this field,” said Dr. Warshel.

While noting that Shenzhen is rapidly advancing in science and technology, he described the city as energetic and attractive. He also praised the remarkable progress of CUHK-SZ, which has evolved into a leading university over the past 10 years.

Prof. Ye Dequan, director of the CUHK-SZ Futian Biomedical Innovation R&D Center, gave a detailed introduction to the center, which was officially established in 2020. Dedicated to R&D of new drugs and disease diagnosis, the center has established four R&D platforms.